Innovative diagnostic and advanced treatment options for liver, pancreatic, gallbladder and bile duct cancers.
Hepato-pancreato-biliary (HPB) cancers originate in the liver (hepato), pancreas (pancreato), gall bladder and bile ducts (biliary). These cancers are often complex and challenging to treat, requiring a multidisciplinary approach to care and treatment, due to their aggressive natures and tendency to be diagnosed at late stages.
Thankfully, advanced diagnostics, which facilitate early detection, and innovative treatment approaches are improving outcomes for patients with liver cancer, pancreatic cancer and cancer of the gall bladder and bile ducts.
Cleveland Clinic Abu Dhabi’s Oncology Institute offers patients with HPB cancers the highest level of care. Meeting weekly as a multidisciplinary tumor board, our Gastrointestinal Cancer team consists of highly skilled specialists offering expert discussions to ensure a comprehensive and holistic approach to care, creating tailored patient-centered treatment plans to ensure the best possible outcomes.
Liver cancer can originate from the liver (primary cancer) or start in another organ, commonly the colon, rectum, pancreas, or breast, and spread to the liver (secondary cancers or liver metastases).
Liver cancer can affect people of any age. In the early stages, it often has no symptoms. Only when the cancer has advanced, the following symptoms may be noticed:
Usually, the cause of liver cancer is not known, but diseases such as hepatitis and cirrhosis of the liver can cause liver cancer.
Learn more about our Liver Cancer Program here.
Our pancreas is a small gland that helps us to digest food and regulates our blood sugar levels by producing insulin and glucagon. Most pancreatic cancers are caused by tumors which begin in the ducts of the pancreas (called adenocarcinoma).
Unfortunately, pancreatic cancer often has no symptoms until it has advanced. As it progresses, symptoms of pancreas cancer may include:
Learn more about our Pancreatic and Biliary Cancer Program here.
Biliary cancers are rare diseases, with different types being named after where the cancer has formed. Bile duct cancer (also call cholangiocarcinoma) begins in either the bile ducts inside the liver (called intrahepatic) or in the bile ducts outside the liver (called extrahepatic). Gall bladder cancer begins in the walls of the gallbladder.
Risk factors for bile duct and gallbladder cancer include:
Learn more about our Pancreatic and Biliary Cancer Program here.
Important technological advancements in the diagnosis of HPB cancer mean that these complex diseases are being diagnosed earlier. Advanced diagnostic tools include:
Learn more about innovation in the diagnosis and treatment of HPB cancers here.
Advanced treatment options are supporting better outcomes for patients with HPB cancers. Being treated at a center that provides a comprehensive range of treatment options is key to successfully treating the disease. These include complex surgery options, which can be curative in early-stage cancers.
Surgery may be combined with targeted chemotherapy, advanced radiotherapy techniques and innovative immunotherapy options, depending on the cancer stage and type.
Read more about surgical treatment options for HPB cancers here.
Our Gastrointestinal Cancer team offers a comprehensive and holistic approach to HPB cancer care. The multidisciplinary team creates tailored, patient-centered treatment plans for every patient, to ensure the best possible outcomes.
Led by an expert team of HPB surgeons, the diverse team includes biliary and pancreatic, colorectal surgeons, hepatologists, gastroenterologists, medical and radiation oncologists, intensivists, specialized pathologists and radiologists, genetic counselor and dedicated nursing and support staff.
Get in touch to talk to our team about Liver Disease, or request an appointment with one of our experts.
Request an Appointment 800 8 2223